These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22099638)

  • 1. Prevalence of neuroleptic-induced restless legs syndrome in patients taking neuroleptic drugs.
    Jagota P; Asawavichienjinda T; Bhidayasiri R
    J Neurol Sci; 2012 Mar; 314(1-2):158-60. PubMed ID: 22099638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restless legs syndrome induced by escitalopram: case report and review of the literature.
    Page RL; Ruscin JM; Bainbridge JL; Brieke AA
    Pharmacotherapy; 2008 Feb; 28(2):271-80. PubMed ID: 18225972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The low prevalence of primary restless legs syndrome in Thai Parkinson's disease patients at Chulalongkorn University Hospital.
    Jagota P; Asawavichienjinda T; Bhidayasiri R
    J Med Assoc Thai; 2012 Feb; 95(2):175-80. PubMed ID: 22435246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olanzapine-induced restless legs syndrome.
    Zhao M; Geng T; Qiao L; Zhang M; Shi J; Huang F; Lin X; Wang J; Zuo H
    J Clin Neurosci; 2014 Sep; 21(9):1622-5. PubMed ID: 24874697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mirtazapine-induced worsening of restless legs syndrome (RLS) and ropinirole-induced psychosis: challenges in management of depression in RLS.
    Chopra A; Pendergrass DS; Bostwick JM
    Psychosomatics; 2011; 52(1):92-4. PubMed ID: 21300203
    [No Abstract]   [Full Text] [Related]  

  • 6. Restless Legs Syndrome among patients receiving antipsychotic and antidepressant drugs.
    Elrassas HH; Elsayed YAR; Abdeen MS; Shady MM; Shalash A; Morsy M
    Hum Psychopharmacol; 2022 Mar; 37(2):e2817. PubMed ID: 34533852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medications associated with restless legs syndrome: a case-control study in the US Renal Data System (USRDS).
    Bliwise DL; Zhang RH; Kutner NG
    Sleep Med; 2014 Oct; 15(10):1241-5. PubMed ID: 25156752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regular intake of non-opioid analgesics is associated with an increased risk of restless legs syndrome in patients maintained on antidepressants.
    Leutgeb U; Martus P
    Eur J Med Res; 2002 Aug; 7(8):368-78. PubMed ID: 12204845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective serotonin reuptake inhibitors and the risk of restless legs syndrome: a symmetry analysis.
    Dunvald AD; Henriksen DP; Hallas J; Christensen MMH; Lund LC
    Eur J Clin Pharmacol; 2020 May; 76(5):719-722. PubMed ID: 32062781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restless leg syndrome associated with olanzapine: a case series.
    Aggarwal S; Dodd S; Berk M
    Curr Drug Saf; 2010 Apr; 5(2):129-31. PubMed ID: 20406161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does domperidone potentiate mirtazapine-associated restless legs syndrome?
    Chang CC; Shiah IS; Chang HA; Mao WC
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):316-8. PubMed ID: 16309808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The restless legs syndrome can be treated with dopamine agonists].
    Aramideh M; de Weerd AW
    Ned Tijdschr Geneeskd; 2006 Oct; 150(40):2173-7. PubMed ID: 17061425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Restless legs syndrome in patients on dialysis for kidney insufficiency: effect of medication].
    Hohl-Radke F; Aedtner F; Domröse U; Neumann KH; Staedt J
    Dtsch Med Wochenschr; 2008 Jan; 133(3):71-5. PubMed ID: 18186007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical and polysomnographic comparison of neuroleptic-induced akathisia and the idiopathic restless legs syndrome.
    Walters AS; Hening W; Rubinstein M; Chokroverty S
    Sleep; 1991 Aug; 14(4):339-45. PubMed ID: 1682986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depressive disorders in restless legs syndrome: epidemiology, pathophysiology and management.
    Hornyak M
    CNS Drugs; 2010 Feb; 24(2):89-98. PubMed ID: 20088617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor Use as a Predictor of a Diagnosis of Restless Legs Syndrome.
    Bailey AL; Makela EH; Asberg K
    J Psychiatr Pract; 2016 Jul; 22(4):263-9. PubMed ID: 27427838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restless legs syndrome as side effect of second generation antidepressants.
    Rottach KG; Schaner BM; Kirch MH; Zivotofsky AZ; Teufel LM; Gallwitz T; Messer T
    J Psychiatr Res; 2008 Nov; 43(1):70-5. PubMed ID: 18468624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of the cumulative incidence and course of restless legs syndrome in de novo patients with Parkinson's disease during chronic dopaminergic therapy.
    Marchesi E; Negrotti A; Angelini M; Goldoni M; Abrignani G; Calzetti S
    J Neurol; 2016 Mar; 263(3):441-7. PubMed ID: 26566909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-Induced Restless Legs Syndrome.
    Patatanian E; Claborn MK
    Ann Pharmacother; 2018 Jul; 52(7):662-672. PubMed ID: 29482354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epilepsy and restless legs syndrome.
    Geyer JD; Geyer EE; Fetterman Z; Carney PR
    Epilepsy Behav; 2017 Mar; 68():41-44. PubMed ID: 28109988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.